Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,741Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Briviact

PharmaCompass

01

Brand Name : Briviact

Brivaracetam

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Briviact

arrow
Pharmtech & Ingredients
Not Confirmed

Brivaracetam

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 241

2018 Revenue in Millions : 155

Growth (%) : 56

blank

02

Brand Name : Briviact

Brivaracetam

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Briviact

arrow
Pharmtech & Ingredients
Not Confirmed

Brivaracetam

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 348

2019 Revenue in Millions : 267

Growth (%) : 30

blank

03

Brand Name : Briviact

Brivaracetam

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Briviact

arrow
Pharmtech & Ingredients
Not Confirmed

Brivaracetam

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 391

2020 Revenue in Millions : 348

Growth (%) : 23

blank

04

Brand Name : Briviact

Brivaracetam

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Briviact

arrow
Pharmtech & Ingredients
Not Confirmed

Brivaracetam

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 517

2021 Revenue in Millions : 391

Growth (%) : 32

blank

05

Brand Name : Briviact

Brivaracetam

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Briviact

arrow
Pharmtech & Ingredients
Not Confirmed

Brivaracetam

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 622

2022 Revenue in Millions : 517

Growth (%) : -16

blank

06

Brand Name : Briviact

Brivaracetam

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Briviact

arrow
Pharmtech & Ingredients
Not Confirmed

Brivaracetam

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 160

2017 Revenue in Millions : 97

Growth (%) : 65%

blank